Citations

Showing 10 of 108162 citations.

Surgical Strategies for Lymphocele Prevention in Minimally Invasive Radical Prostatectomy and Lymph Node Dissection: A Systematic Review
Motterle, Giovanni , Morlacco, Alessandro , Zanovello, Nicola, Zattoni, Filiberto, Karnes, R. Jeffrey , Moro, Fabrizio , Karnes, Robert Jeffrey, Ahmed, Mohamed E.

Mayo Clinic

Journal of Endourology | December 4, 2019 | Volume: 34 | Issue: 2 | Pages: 113-120

10.1089/end.2019.0716 | PMID 31797684 Get It

Purpose: Pelvic lymph node dissection is an important step during robotic radical prostatectomy. The collection of lymphatic fluid (lymphocele) is the most common complication with potentially severe impact; therefore, different strategies have been proposed to reduce its incidence. Materials and Methods: In this systematic review, EMBASE, MEDLINE, Cochrane Library, and NIH Registry of Clinical Trials were searched for articles including the following interventions: transperitoneal vs extraperitoneal approach, any reconfiguration of the peritoneum, the use of pelvic drains, and the use of different sealing techniques and sealing agents. The outcome evaluated was the incidence of symptomatic lymphocele. Randomized, nonrandomized, and/or retrospective studies were included. Results: Twelve studies were included (including one ongoing randomized clinical trial). Because of heterogeneity of included studies, no meta-analysis was performed. No significant impact was reported by different sealing techniques and agents or by surgical approach. Three retrospective, nonrandomized studies showed a potential benefit of peritoneal reconfiguration to maximize the peritoneal surface of reabsorption. Conclusion: Lymphocele formation is a multistep and multifactorial event; high-quality literature analyzing risk factors and preventive measures is rather scarce. Peritoneal reconfiguration could represent a reasonable option that deserves further evaluation; no other preventive measure is supported by current evidence.
Left ventricular extracellular volume expansion does not predict recurrence of atrial fibrillation following catheter ablation
Gunasekaran, Suvai , Lee, Daniel , Knight, Bradley P. , Fan, Lexiaozi , Trivedi, Amar, Ragin, Ann , Carr, James , Kim, Daniel , Collins, Jeremy D. , Kim, Daniel , Knight, Bradley P , Lee, Daniel C , Passman, Rod

Mayo Clinic

Pacing and Clinical Electrophysiology | December 4, 2019 | Volume: 43 | Issue: 2 | Pages: 159-166

10.1111/pace.13853 | PMID 31797387 Get It

AbstractIntroductionA recent study reported that diffuse left ventricular (LV) fibrosis is a predictor of atrial fibrillation (AF) recurrence following catheter ablation, by measuring postcontrast cardiac T1 (an error prone metric as per the 2017 Society for Cardiovascular Magnetic Resonance consensus statement) using an inversion‐recovery pulse sequence (an error prone method in arrhythmia) in AF ablation candidates. The purpose of this study was to verify the prior study, by measuring extracellular volume (ECV) fraction (an accurate metric) using a saturation‐recovery pulse sequence (accurate method in arrhythmia).Methods and ResultsThis study examined 100 AF patients (mean age = 62 ± 11 years, 69 males and 31 females, 67 paroxysmal [pAF] and 33 persistent [peAF]) who underwent a preablation cardiovascular magnetic resonance (CMR) exam. LV ECV and left atrial (LA) and LV functional parameters were quantified using standard analysis methods. During an average follow‐up period of 457 ± 261 days with 4 ± 3 rhythm checks per patient, 72 patients maintained sinus rhythm. Between those who maintained sinus rhythm (n = 72) and those who reverted to AF (n = 28), the only clinical characteristic that was significantly different was age (60 ± 12 years vs 66 ± 9 years); for CMR metrics, neither mean LV ECV (25.1 ± 3.3% vs 24.7 ± 3.7%), native LV T1 (1093.8 ± 73.5 ms vs 1070.2 ± 115.9 ms), left ventricular ejection fraction (54.1 ± 11.2% vs 55.7 ± 7.1%), nor LA end diastolic volume/body surface area (42.4 ± 14.8 mL/m2 vs 43.4 ± 19.6 mL/m2) were significantly different (P ≥ .23). According to Cox regression tests, none of the clinical and imaging variables predict AF recurrence.ConclusionNeither LV ECV nor other CMR metrics predict recurrence of AF following catheter ablation.
Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration
Neal, Matthew L., Fleming, Sheila M. , Budge, Kevin M., Boyle, Alexa M., Kim, CK , Alam, Gelareh, Beier, Eric E., Wu, Long‐Jun , Richardson, Jason R. , Wu, Long-Jun , Kim, Chunki , Neal, Matthew P

Mayo Clinic

The FASEB Journal | December 4, 2019 | Volume: 34 | Issue: 1 | Pages: 1679-1694

10.1096/fj.201900567rr | PMID 31914683 Get It

Abstract Increased pro‐inflammatory cytokine levels and proliferation of activated microglia have been found in Parkinson's disease (PD) patients and animal models of PD, suggesting that targeting of the microglial inflammatory response may result in neuroprotection in PD. Microglial proliferation is regulated by many factors, but colony stimulating factor‐1 receptor (CSF1R) has emerged as a primary factor. Using data mining techniques on existing microarray data, we found that mRNA expression of the CSF1R ligand, CSF‐1, is increased in the brain of PD patients compared to controls. In two different neurotoxic mouse models of PD, acute MPTP and sub‐chronic LPS treatment, mRNA and protein levels of CSF1R and CSF‐1 were significantly increased. Treatment with the CSF1R inhibitor GW2580 significantly attenuated MPTP‐induced CSF1R activation and Iba1‐positive cell proliferation, without a reduction of the basal Iba1‐positive population in the substantia nigra. GW2580 treatment also significantly decreased mRNA levels of pro‐inflammatory factors, without alteration of anti‐inflammatory mediators, and significantly attenuated the MPTP‐induced loss of dopamine neurons and motor behavioral deficits. Importantly, these effects were observed in the absence of overt microglial depletion, suggesting that targeting CSF1R signaling may be a viable neuroprotective strategy in PD that disrupts pro‐inflammatory signaling, but maintains the beneficial effects of microglia.
Staphylococcus pseudintermedius catheter-related bloodstream infection after exposure to domestic dogs and a cat
Diaz, Mark Anthony , Gardner, Lindsay B., Libertin, Claudia R. , Libertin, Claudia

Mayo Clinic

BMJ Case Reports | December 4, 2019 | Volume: 12 | Issue: 12 | Pages: e231489

10.1136/bcr-2019-231489 | PMID 31801778 Get It

We report a case of a catheter-related bloodstream infection due to oxacillin-susceptible Staphylococcus pseudintermedius in a patient receiving haemodialysis who possibly acquired the organism from her pets. Because of persistent bacteremia and the organism’s ability to form biofilm, catheter removal and antimicrobial therapy were indicated to attain source control. Both clinical and microbiological cure were confirmed. Catheter care education should include information about pet exposure and the possibility of zoonotic infections.
Incidence and risk factors for hardware removal following periacetabular osteotomy and its association with clinical outcomes
Statz, Joseph M. , Trousdale, Robert T. , Wyles, Cody C. , Chalmers, Brian P. , Hevesi, Mario , Sierra, Rafael J.

Mayo Clinic

HIP International | December 4, 2019 | Volume: 31 | Issue: 3 | Pages: 410-416

10.1177/1120700019890852 | PMID 31795753 Get It

Background: Periacetabular osteotomy (PAO) can be used for joint preservation in symptomatic developmental dysplasia of the hip (DDH) and femoroacetabular impingement (FAI). 1 of the most common procedures following PAO is hardware removal. The aims of this study were to determine the rate of hardware removal and patient characteristics associated with this outcome following PAO. Methods: Data from a prospectively-collected registry was retrospectively reviewed at one institution managing DDH or FAI patients with PAO from July 2008–December 2015. Patients who completed preoperative and postoperative patient reported outcome (PRO) questionnaires with minimum 1-year follow-up were evaluated, resulting in 221 patients followed for a mean of 2.8 years (range 1.0–7.7 years). There were 80% women, mean age was 25 years and mean body mass index (BMI) was 25 kg/m 2 . Fully-threaded 4.5-mm screws were used for internal fixation. Results: Hardware removal occurred in 30 patients (13.6%) at a mean of 1.0 years after PAO. Patients undergoing hardware removal were younger (mean age 20.4 vs. 26.3 years), thinner (mean BMI 22.2 vs. 25.1), had less severe dysplasia (DDH patients only: mean lateral centre-edge angle 21.0 vs. 16.2, mean Tönnis angle 12.9 vs. 16.8), and were more likely to have PAO for FAI (33% vs. 11%) compared to patients with retained hardware. At final follow-up, multivariable analysis demonstrated a trend toward inferior patient reported outcomes in the hardware removal group. Conclusions: This study defines the incidence and characteristics of patients undergoing hardware removal after PAO and demonstrates similar outcomes to patients who do not require hardware removal.
Renal artery injury during inferior vena cava filter removal with endobronchial forceps
Padula, Carlos A. , Lewis, Andrew R. , Frey, G. , McKinney, J. Mark , Paz‐Fumagalli, Ricardo , Ritchie, Charles , Devcic, Zlatko , Toskich, Beau B. , Frey, Gregory T, Ritchie, Charles A

Mayo Clinic

JRSM Cardiovascular Disease | December 4, 2019 | Volume: 8 | Issue: No issue available | Pages: No page available

10.1177/2048004019893513 | PMID 31839940 Get It

Retrieval of tip-embedded inferior vena cava filters using endobronchial forceps is a well-described technique. The tip of dorsally tilted filters may be in proximity to the right renal artery, increasing the risk of arterial injury during retrieval. We present one case that illustrates renal artery injury requiring emergent stent graft repair. The three subsequent cases illustrate techniques that avoid renal artery injury using a femoral and jugular approach with the assistance of an arterial fiducial wire. Renal artery injury is a potential complication during retrieval of filters using endobronchial forceps that can be prevented with careful planning.
In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy
Ito, Fumito , Vardam, Trupti D., Appenheimer, Michelle M., Eng, Kevin H. , Gollnick, Sandra O. , Muhitch, Jason B. , Evans, Sharon S.

Mayo Clinic

International Journal of Hyperthermia | December 3, 2019 | Volume: 36 | Issue: sup1 | Pages: 22-36

10.1080/02656736.2019.1653500 | PMID 31795828 Get It

Behavioral aspects of vestibular rehabilitation
Staab, Jeffrey P. , Staab, Jeffrey P

Mayo Clinic

NeuroRehabilitation | December 3, 2019 | Volume: 29 | Issue: 2 | Pages: 179-183

10.3233/nre-2011-0693 | PMID 22027080 Get It

Psychology: Current practice and training issues in treatment of cognitive dysfunction
Bergquist, Thomas F. , Malec, James F.

Mayo Clinic

NeuroRehabilitation | December 3, 2019 | Volume: 8 | Issue: 1 | Pages: 49-56

10.3233/nre-1997-8107 | PMID 24525944 Get It

Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants
ElHassan, Nahed O. , Bird, T. Mac , Ambadwar, Pratibha B., Jaquiss, Robert D.B. , Robbins, James M. , King, Anthony J , Kaiser, Jeffrey R.

Mayo Clinic

Journal of Neonatal-Perinatal Medicine | December 3, 2019 | Volume: 7 | Issue: 3 | Pages: 229-235

10.3233/npm-14814015 | PMID 25322995 Get It

BACKGROUND: Patent ductus arteriosus (PDA) occurs in 70% of extremely low birth weight (ELBW, birth weight <1000 g) infants. Approximately 34% of ELBW infants with a PDA have spontaneous closure. Failure of the ductus arteriosus to close has been associated with multiple morbidities. OBJECTIVE: To examine variability over time and across hospitals in early therapeutic (2–7 day) use of indomethacin (INDO) vs ibuprofen (IBU) for PDA treatment in outborn ELBW infants and examine the outcomes and side effects of both pharmacological agents in this population. METHODS: Data were extracted from the Pediatric Health Information System. ELBW infants born between January 1, 2007 and December 31, 2010 and admitted on day of life 0 were eligible for inclusion. 732 infants had a PDA diagnosis and met inclusion criteria. We explored the variability in PDA pharmacotherapy over time and across hospitals. We compared outcomes of both agents for in-hospital mortality, need for surgical ligation, intraventricular hemorrhage, necrotizing enterocolitis, bronchopulmonary dysplasia, periventricular leukomalacia, renal failure, and persistent pulmonary hypertension. Statistical methods included chi square and multivariable regression analysis. Instrumental variable analysis was used to control for selection bias and omitted variables. RESULTS: There was large variability in PDA pharmacotherapy over time and across hospitals. INDO use declined as IBU use grew from 12.8 to 38.9%. There was no difference in hospital or NICU characteristics between high and low IBU using NICUs. Renal failure was more common in infants receiving INDO compared to IBU. CONCLUSION: We noted large variability in PDA pharmacotherapy. Renal failure was more common with INDO use. Until further studies to compare the long-term effects of both drugs, our data support IBU as the preferred medication for PDA pharmacotherapy in ELBW infants.